Moderna is basing its new HIV vaccine on mRNA technology, the same technology used in its COVID-19 vaccine. Neither vaccine includes any form of either the coronavirus on HIV. (K.M.
Chaudary/Associated Press) Can Moderna’s new mRNA vaccine produce the immune response needed to prevent HIV infection? DAVID TAFFET | Senior Staff Writertaffet@dallasvoice.com The new HIV vaccine Moderna is testing uses the same mRNA technology the pharmaceutical company uses in its COVID-19 vaccine.
And the goal is to stimulate the patient’s immune system to create antibodies to the HIV virus. The first phase of human trials will test the vaccine’s safety and see if the vaccine is producing an immune response.